IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 12.093
AS - Asia 9.740
EU - Europa 2.953
SA - Sud America 581
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 5
Totale 25.466
Nazione #
US - Stati Uniti d'America 12.011
HK - Hong Kong 6.425
SG - Singapore 1.450
CN - Cina 833
IT - Italia 716
UA - Ucraina 705
BR - Brasile 501
VN - Vietnam 441
RU - Federazione Russa 382
DE - Germania 364
IE - Irlanda 226
TR - Turchia 223
FI - Finlandia 179
KR - Corea 177
SE - Svezia 175
GB - Regno Unito 69
IN - India 49
CA - Canada 35
AR - Argentina 34
MX - Messico 31
PL - Polonia 29
BD - Bangladesh 26
NL - Olanda 24
JP - Giappone 23
ZA - Sudafrica 21
EU - Europa 20
AT - Austria 14
ES - Italia 14
FR - Francia 14
ID - Indonesia 14
IQ - Iraq 14
EC - Ecuador 13
KE - Kenya 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
PY - Paraguay 9
PK - Pakistan 8
UZ - Uzbekistan 7
VE - Venezuela 7
AZ - Azerbaigian 5
CL - Cile 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
NP - Nepal 4
SN - Senegal 4
TN - Tunisia 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BH - Bahrain 3
CI - Costa d'Avorio 3
CO - Colombia 3
DZ - Algeria 3
GH - Ghana 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
NG - Nigeria 3
RS - Serbia 3
SA - Arabia Saudita 3
BB - Barbados 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
YT - Mayotte 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MG - Madagascar 1
ML - Mali 1
NC - Nuova Caledonia 1
NE - Niger 1
Totale 25.457
Città #
Hong Kong 6.419
Ann Arbor 2.883
Wilmington 2.392
Jacksonville 882
Woodbridge 854
Chandler 846
Singapore 694
Princeton 691
Houston 571
Dallas 445
Dong Ket 307
Ashburn 263
Dublin 225
Izmir 205
Nanjing 159
Andover 158
Boardman 158
Pellezzano 138
Mestre 135
Beijing 133
Moscow 124
Dearborn 97
Munich 88
Salerno 86
Los Angeles 83
Düsseldorf 80
Fairfield 71
Changsha 55
Shenyang 53
Ho Chi Minh City 50
São Paulo 49
New York 48
The Dalles 46
Hebei 44
Falls Church 42
Nanchang 42
Jiaxing 32
Saint Petersburg 32
Napoli 31
Norwalk 31
Milan 27
Turku 25
Hanoi 24
Rome 24
San Francisco 24
Tianjin 24
Warsaw 24
Venezia 23
San Diego 22
Tokyo 22
Santa Clara 21
London 19
Montreal 19
Jinan 18
Nuremberg 18
Brooklyn 17
Grevenbroich 17
Redwood City 17
Rio de Janeiro 17
Columbus 16
Johannesburg 16
Naples 16
Cambridge 15
Guangzhou 15
Phoenix 15
Denver 14
Stockholm 14
Washington 14
Pune 13
Seattle 12
Seoul 12
Atlanta 11
Charlotte 11
Lappeenranta 11
Manchester 11
Shanghai 11
Amsterdam 10
Boston 10
Council Bluffs 10
Mexico City 10
Poplar 10
Chennai 9
Belo Horizonte 8
Brasília 8
Buffalo 8
Nairobi 8
Salvador 8
Tappahannock 8
Ankara 7
Bari 7
Helsinki 7
Mumbai 7
Orem 7
Tashkent 7
Baghdad 6
Biên Hòa 6
Brno 6
Chicago 6
Curitiba 6
Dhaka 6
Totale 20.556
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 852
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 837
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 547
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 501
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 483
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 410
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 400
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 293
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 277
Adrenergic signaling in heart failure and cardiovascular aging 268
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 265
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 257
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 256
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 251
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 238
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 234
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 229
Serum uric acid and left ventricular mass in essential hypertension 226
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 224
Thyroid function predicts increased cardiovascular risk 219
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 199
Characterization of a selective CaMKII peptide inhibitor 193
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 192
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 188
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 185
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 183
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 183
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 180
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 179
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 179
AKT participates in endothelial dysfunction in hypertension. 172
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 169
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 168
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 163
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 160
Targeting myocardial remodelling to develop novel therapies for heart failure 160
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 155
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 151
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 150
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 149
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 146
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 145
Active and Healthy Ageing and Independent Living 142
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 141
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 138
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 138
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 137
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 136
Active and Healthy Ageing and Independent Living 2016 136
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 135
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 135
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 133
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 133
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 132
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 130
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 130
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 130
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 128
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 128
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 127
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 127
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 127
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 126
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 125
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 124
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 123
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 123
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 122
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 122
G Protein-Coupled Receptor Kinases and Hypertension 122
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 121
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 121
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 120
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 120
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 117
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 117
CaMK4 Gene Deletion Induces Hypertension 117
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 117
Insufficient control of blood pressure and incident diabetes. 116
External support modulates G protein expression and receptor coupling in experimental vein grafts. 115
Good at Heart: Preserving Cardiac Metabolism during aging 115
Atrial fibrillation and microRNAs 115
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 114
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 114
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 113
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 111
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 110
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 110
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 110
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 109
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 109
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. 108
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 108
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 108
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 108
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. 106
Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts 106
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. 105
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 105
GRK2 at the control shaft of cellular metabolism 105
Totale 18.036
Categoria #
all - tutte 78.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021895 0 0 0 0 0 49 167 17 164 5 148 345
2021/20221.236 3 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/20269.129 1.316 3.436 2.799 475 955 148 0 0 0 0 0 0
Totale 25.911